Intravenous Infusion Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The latest report reveals that global sales for the Intravenous Infusion Pumps Market in 2024 reached US$6 billion. Projected to grow at a CAGR of 11% from 2024 to 2031, the market is expected to reach US$12.5 billion. The absolute dollar opportunity for the market, driven by increased demand for intravenous infusion pumps in healthcare facilities like hospitals and nursing homes.

What will be the growth prospects of the Intravenous Infusion Pumps Market?

Chronic illnesses, responsible for 80% of deaths in low- and middle-income nations, encompass cardiovascular diseases, stroke, cancer, chronic respiratory diseases, and diabetes. Cardiovascular disease is the leading global cause of mortality, as per the World Health Organization. The incidence of cancer worldwide has sharply risen to 18.1 million cases in 2018. This surge in chronic illnesses, including cardiovascular disease and cancer, has driven the demand for intravenous infusion pumps. The increased disease burden also heightens the risk of drug errors, necessitating safer and more standardized delivery methods. The development of smart intravenous infusion pumps, or next-generation pumps, with computerized features aims to minimize dosage errors and enhance error-free medical care, contributing to market growth.

Which Region is projected to Offer the Largest Opportunity for Intravenous Infusion Pumps Market?

The Asia Pacific is anticipated to experience the fastest growth in Intravenous Infusion Pumps Market revenue. The region's increasing aging population, coupled with a growing middle class, is expected to drive demand in the coming years. UNFPA research indicates that the APAC region's aging population is rapidly expanding, with one in four individuals projected to be over 60 by 2050, reaching a total population of nearly 1.3 billion.

Country-wise Analysis

The United States leads the global Intravenous Infusion Pumps Market and is projected to reach US$5.1 billion by 2031, driven by favorable factors such as reimbursement policies and technological advancements. The country's growing geriatric population is a key driver, with projections indicating an increase from 52 million in 2018 to nearly 95 million by 2060. North America is expected to hold a significant market share due to the prevalence of chronic illnesses, accounting for over 75% of healthcare expenses. The adoption of technologically advanced products, awareness of modern intravenous infusion pumps, and a well-established healthcare infrastructure contribute to the market's growth.

Key Companies Profiled

• BAXTER INTERNATIONAL
• B. BRAUN MELSUNGEN AG
• MEDTRONIC
• MICREL MEDICAL DEVICES SA
• BOSTON SCIENTIFIC CORPORATION
• CAREFUSION CORPORATION
• FRESENIUS KABI
• SMITHS MEDICAL

Market Segments Covered in Intravenous Infusion Pumps Industry Analysis

By Infusion Pumps Type

• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Enteral Infusion Pumps
• Ambulatory Infusion Pumps
• Patient-Controlled Analgesia Infusion Pumps
• Implantable Infusion Pumps
• Other Infusion Pumps Types

By Disease Indication

• Chemotherapy
• Diabetes
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics /Neonatology
• Hematology
• Other Disease Indications

By Region

• North America
• Latin America
• Europe
• APAC
• MEA

This product will be delivered within 1-3 business days.